In silico and in vitro screening of licensed antimalarial drugs for repurposing as inhibitors of hepatitis E virus.
Borris Rosnay Tietcheu GalaniVincent Brice Ayissi OwonaRomeo Joel Guemmogne TemdieKaroline MetzgerMarie Atsama AmougouPascal Dieudonné Djamen ChuisseuArnaud Fondjo KouamMarceline Ngounoue DjuidjeCécile-Marie Aliouat-DenisLaurence CocquerelPaul Fewou MoundipaPublished in: In silico pharmacology (2021)
The online version contains supplementary material available at 10.1007/s40203-021-00093-y.